The role of grace periods in comparative effectiveness studies of different medications
share
Researchers are often interested in estimating the effect of sustained use of a pharmacological treatment on a health outcome. However, adherence to strict treatment protocols can be challenging for patients in practice and, when non-adherence is expected, estimates of the effect of sustained use may not be useful for decision making. As an alternative, more relaxed treatment protocols which allow for periods of time off treatment (i.e. grace periods) have been considered in pragmatic randomized trials and observational studies. In this paper we consider the interpretation, identification, and estimation of treatment strategies which include grace periods. We contrast natural grace period strategies which allow individuals the flexibility to take treatment as they would naturally do, with stochastic grace period strategies in which the investigator specifies the distribution of treatment utilization. We estimate the effect of initiation of a thiazide diuretic or an angiotensin-converting enzyme inhibitor (ACEI) in hypertensive patients under various strategies which include grace periods. We find that the risk of adverse cardiovascular and cerebrovascular outcomes is higher under treatment with ACEIs, and that this difference is larger under grace period strategies which impose lower drug utilization.
READ FULL TEXT
